Home › Neuroblastoma › New Jersey › Clifton
Neuroblastoma clinical trials in Clifton, NJ
4 studies for Neuroblastoma are looking for participants at sites in and around Clifton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi away
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingPhase 3
- Hackensack University Medical Center, Hackensack · 7 mi away
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RecruitingPhase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi away
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RecruitingPhase 3
- Hackensack University Medical Center, Hackensack · 7 mi away
About Neuroblastoma
Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.
More about Neuroblastoma on MedlinePlus
Neuroblastoma trials in other cities
- Boston, MA13 studies
- New York City, NY12 studies
- Washington, DC11 studies
- Dallas, TX10 studies
- Cincinnati, OH9 studies
- St. Louis, MO9 studies
- Memphis, TN9 studies
- Philadelphia, PA9 studies
- Aurora, CO9 studies
- Hartford, CT8 studies
- Birmingham, AL8 studies
- Harrisburg, PA8 studies
Other studies in Clifton
- Non-Small Cell Lung Cancer23 studies
- Multiple Myeloma15 studies
- Cancer (all types)13 studies
- Prostate Cancer12 studies
- Acute Myeloid Leukemia11 studies
- Ovarian Cancer11 studies
- Metastatic Cancer11 studies
- Breast Cancer11 studies
- Colorectal Cancer9 studies
- Lung Cancer9 studies
- Heart Failure9 studies
- Leukemia8 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.